Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Breast Cancer Research
Published in: Breast Cancer Research 2/2009

01-10-2009 | Poster presentation

Negative axillary ultrasound in primary breast cancer: how reassured should we really be?

Authors: SJ Hall, SE Brown, GJR Porter, J Steel, K Paisley, RM Watkins, C Holgate

Published in: Breast Cancer Research | Special Issue 2/2009

Login to get access

Excerpt

Axillary ultrasound has become an important adjunct in the staging of breast cancer in recent years. We retrospectively studied a sample of 155 women with invasive breast cancer and normal axillary ultrasound to investigate whether the characteristics of the primary tumour could predict the likelihood of false negative axillary ultrasound. …
Metadata
Title
Negative axillary ultrasound in primary breast cancer: how reassured should we really be?
Authors
SJ Hall
SE Brown
GJR Porter
J Steel
K Paisley
RM Watkins
C Holgate
Publication date
01-10-2009
Publisher
BioMed Central
Published in
Breast Cancer Research / Issue Special Issue 2/2009
Electronic ISSN: 1465-542X
DOI
https://doi.org/10.1186/bcr2390

Other articles of this Special Issue 2/2009

Breast Cancer Research 2/2009 Go to the issue

Poster presentation

Axillary ultrasound in staging breast cancer: diagnostic accuracy and effect on subsequent axillary surgery - the Plymouth experience

Poster presentation

Is it safe practice not to biopsy fibroadenomas in women under 30?

Poster presentation

Can we predict the likelihood of malignancy in mammographically indeterminate microcalcification?

Poster presentation

Comparison of ultrasound localisation techniques for impalpable breast cancer

Oral presentation

Interval cancer review in the Leicestershire symptomatic breast service

Poster presentation

Breast cancer screening - how do we communicate with women of South Asian origin?
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits